Market Place
Sourcing Support
Upsher-Smith Selects PANTHERx Rare For Distribution Of TORPENZ
20 Aug 2024 //
PR NEWSWIRE
Upsher-Smith Launches TORPENZ™ Tablets For Rare Diseases
05 Aug 2024 //
PR NEWSWIRE
Merck’s WELIREG Improved Objective Response Rates Versus Everolimus in RCC
21 Oct 2023 //
BUSINESSWIRE
Par Pharm`s Generic Everolimus Receives Approval in US
22 Oct 2021 //
FDA
Biocon expands its Generic portfolio with the launch of Everolimus tablets
04 Oct 2021 //
EQUITYBULLS
Breckenridge Pharma launches generic Afinitor in US market
01 Oct 2021 //
PHARMABIZ
Breckenridge Announces Final Approval of its ANDA for Everolimus Tablets
08 Mar 2021 //
PRNEWSWIRE
Breckenridge Announces Final Approval of its ANDA for Everolimus Tablets
08 Mar 2021 //
PRNEWSWIRE
Farmhispania Group has Awarded With The First CEP For Everolimus
02 Feb 2021 //
PRESS RELEASE
Mylan`s Generic Everolimus Receives Approval In US
16 Jun 2020 //
FDA
Hikma`s Generic Everolimus Receives Approval In US
15 Jun 2020 //
FDA
Mylan Pharms`s Generic Everolimus Receives Approval In Us
09 Jan 2020 //
FDA
Teva Pharms Generic Everolimus Receives Approval in US
13 Dec 2019 //
FDA
Par Pharm`s Generic Everolimus Receives Approval in US
12 Dec 2019 //
FDA
Boosting KRAS inhibitors in lung cancer with a combo
18 Sep 2019 //
FIERCE BIOTECH
Par Pharm`s Generic Everolimus Receives Tentative Approval in US
07 Aug 2019 //
FDA
Novartis Corp. v. West-Ward Pharmaceuticals Int`l (Fed. Cir. 2019)
17 May 2019 //
PATENTDOCS
Novartis defeats challenge to validity of Afinitor patent
15 May 2019 //
REUTERS
Mylan Pharms Generic Everolimus Receives Approval in US
25 Apr 2019 //
FDA
Teva Pharm USA`s Generic Everolimus Receives Tentative Approval in US
15 Feb 2019 //
FDA
NHS to fund Afinitor for TSC-related epilepsy
04 Jan 2019 //
PHARMA TIMES
AZ drops midstage cancer drug vistusertib
08 Nov 2018 //
FIERCE BIOTECH
Eisai`s Kisplyx (lenvatinib mesilate) Receives Approval for Europe
26 Oct 2018 //
EMA
CHMP report on Novartis` Afinitor use in estrogen receptor+ mBC
20 Oct 2018 //
EMA
Lenvima wins green light in liver cancer
17 Aug 2018 //
PHARMA TIMES
Eisai`s Lenvima posts big growth as Merck collaboration rolls into action
04 Aug 2018 //
FIERCE PHARMA
Generic unprecedented approved for the treatment of cancer
25 Jul 2018 //
ANVISA
Novartis NET app gets an App Store launch boost
23 Jul 2018 //
FIERCE PHARMA
Novartis’ Afinitor Disperz wins new TSC-related approval
11 Apr 2018 //
PHARMA TIMES
Tuberous Sclerosis Alliance salutes FDA approval of Afinitor® DISPERZ
10 Apr 2018 //
PR NEWSWIRE
Rexahn Pharma Announces Collaboration with Zhejiang Haichang Biotechnology
08 Feb 2018 //
GLOBENEWSWIRE
Novartis` Zortress Patent Survives PTAB Challenge
12 Jan 2018 //
LAW360
US FDA issues guidelines to help generic makers to copy 32 complex drug products
20 Oct 2017 //
MONEY CONTROL
Europe backs nuclear medicine for cancer that killed Steve Jobs
21 Jul 2017 //
REUTERS
New or extended uses, or new combinations of registered medicines
05 Jul 2017 //
TGA
US FDA publishes list of off-patent, off-exclusivity branded drugs
28 Jun 2017 //
PHARMABIZ
NICE backs Afinitor, Sutent for neuroendocrine tumours
28 Jun 2017 //
PHARMA TIMES
Par Pharm’s Generic Everolimus Receives Tentative Approval In US
14 Jun 2017 //
FDA
Ipsen in talks with NICE over Cabometyx rejection
21 Apr 2017 //
PHARMA TIMES
Afinitor (Everolimus): Novartis v. Breckenridge Pharmaceuticals
13 Apr 2017 //
PATENT LITIGATION
Afinitor Disperz (Everolimus): Novartis v. Mylan Pharmaceuticals
10 Apr 2017 //
PATENT LITIGATION
Afinitor (Everolimus): Novartis v. Teva Pharmaceuticals
07 Apr 2017 //
PATENT LITIGATION
Novartis’ Afinitor gets NICE green light for kidney cancer
24 Feb 2017 //
PHARMATIMES
Novartis says Votubia receives EU approval for new indication
01 Feb 2017 //
REUTERS
NICE recommends Novartis’ kidney cancer drug
12 Jan 2017 //
PHARMATIMES
Novartis drug Votubia recommended by CHMP for EU approval
16 Dec 2016 //
GLOBENEWSWIRE
NICE reappraisals back Novartis’ Afinitor and Pfizer’s Xalkori
11 Nov 2016 //
PHARMATIMES
SMC Endorses Use of Five Meds on NHS Scotland
08 Nov 2016 //
PHARMATIMES
NICE U-turn on Opdivo for Kidney Cancer
21 Oct 2016 //
PM LIVE
NICE shoots down two CDF drugs
18 Aug 2016 //
PHARMATIMES
Eisai receives positive CHMP opinion on new indication for anticancer agent
29 Jul 2016 //
BIOSPECTRUM ASIA
Novartis announces US collaboration to co-promote Lenvima® in combination
02 Jun 2016 //
PR NEWSWIRE
SMC accepts three new drugs for NHS use, but bans two
12 Apr 2016 //
PHARMATIMES
With $70M in VC cash, Tizona takes a fresh approach to immuno-oncology
09 Mar 2016 //
FIERCE BIOTECH
FDA approves new indication for Novartis drug Afinitor® for progressive,NET
26 Feb 2016 //
PR NEWSWIRE
Pfizer keeps pushing on early hit Ibrance as Novartis, Lilly rivals near market
08 Feb 2016 //
FIERCE PHARMA MARKETING
BMS` Opdivo evens the score in melanoma with two new FDA green lights
26 Jan 2016 //
FIERCE PHARMA
Eisai files kidney cancer drug in Europe
12 Jan 2016 //
PHARMATIMES
Eisai EMA has a new request for authorization to use lenvatinib with everolimus
11 Jan 2016 //
PR NEWS WIRE
